Pyruvate in oral rehydration salt improves hemodynamics, vasopermeability and survival after burns in dogs

Burns. 2016 Jun;42(4):797-806. doi: 10.1016/j.burns.2016.01.012. Epub 2016 Apr 27.

Abstract

Background: To investigate whether pyruvate-enriched oral rehydration solution (Pyr-ORS), compared with citrate-enriched ORS (Cit-ORS), improves hemodynamics and organ function by alleviating vasopermeability and plasma volume loss during intra-gastric fluid rehydration in dogs with severe burn.

Methods: Forty dogs subjected to severe burn were randomly divided into four groups (n=10): two oral rehydrated groups with Pyr-ORS and Cit-ORS (group PR and group CR), respectively, according to the Parkland formula during the first 24h after burns. Other two groups were the intravenous (IV) resuscitation (group VR) with lactated Ringer's solution with the same dosage and no fluid rehydration (group NR). During the next 24h, all groups received the same IV infusion. The hemodynamics, plasma volume, vasopermeability and water contents and function of various organs were determined. Plasma levels of vascular endothelial growth factor (VEGF) and platelet activating factor (PAF) were detected by ELISA.

Results: Hemodynamics parameters were significantly improved in group PR superior to group CR after burns. Levels of VEGF and PAF were significantly lower in group PR than in group CR. Organ function parameters were also greatly preserved in group PR, relative to groups CR and NR. Lactic acidosis was fully corrected and survival increased in group PR (50.0%), compared to group CR (20.0%).

Conclusion: Pyr-ORS was more effective than Cit-ORS in improving hemodynamics, visceral blood perfusion and organ function by alleviating vasopermeability-induced visceral edema and plasma volume loss in dogs with severe burn.

Keywords: Burn; Oral rehydration salt; Organ function; Pyruvate; Shock; Vasopermeability.

MeSH terms

  • Animals
  • Bicarbonates
  • Burns / drug therapy*
  • Burns / mortality
  • Burns / physiopathology
  • Capillary Permeability / drug effects*
  • Disease Models, Animal
  • Dogs
  • Fluid Therapy / methods*
  • Fluorescein-5-isothiocyanate / analysis
  • Glucose
  • Hemodynamics / drug effects*
  • Lactic Acid / metabolism
  • Platelet Activating Factor / metabolism
  • Potassium Chloride
  • Pyruvic Acid / pharmacology*
  • Random Allocation
  • Shock / drug therapy
  • Sodium Chloride
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Bicarbonates
  • Platelet Activating Factor
  • Vascular Endothelial Growth Factor A
  • World Health Organization oral rehydration solution
  • Lactic Acid
  • Sodium Chloride
  • Potassium Chloride
  • Pyruvic Acid
  • Fluorescein-5-isothiocyanate
  • Glucose